Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary

Gynecological Endocrinology

Volumn 11, Issue 6, 1997, Pages 371-381

  Yamamoto, S ^a   Konishi, I ^a   Tsuruta, Y ^a   Nanbu, K ^a   Mandai, M ^a   Kuroda, H ^a   Matsushita, K ^a   Hamid, A A ^a   Yura, Y ^a   Mori, T ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Corpus luteum; Folliculogenesis; Immunohistochemistry; Ovary; Vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CYCLINE; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; FEMALE; GRANULOSA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUTEAL PHASE; MICROVASCULATURE; OVARY DEVELOPMENT; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THECA CELL; VASCULAR ENDOTHELIUM;

EID: 6844250994     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599709152564     Document Type: Article

References (27)

1. Koos, R. D. (1993). Ovarian angiogenesis. In Adashi, E. Y. and Leung, P. C. K. (eds) Comprehensive Endocrinology: The Ovary, pp. 433-53. (New York: Raven Press)
2. Dvorak, H. F., Brown, L. F., Detmar, M. and Dvorak, A. M. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol., 146, 1029-39
3. Neufeld, G., Tessler, S., Gitay-Goren, H., Cohen, T. and Levi, B. Z. (1994). Vascular endothelial growth factor and its receptors. Prog. Growth Factor Res., 5, 89-97
4. Kamat, B. R., Brown, L. F., Manseau, E. J., Senger, D. R. and Dvorak, H. F. (1995). Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am. J. Pathol., 146, 157-65
5. Phillips, H. S., Hains, J., Leung, D. W. and Ferrara, N. (1990). Vascular endothelial growth factor is expressed in rat corpora lutea. Endocrinology, 127, 965-7
6. Ravindranath, N., Little-Ihrig, L., Phillips, H. S., Ferrary, N. and Zeleznik, A. J. (1992). Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology, 131, 254-60
7. Gordon, J. D., Mesiano, S., Zaloudek, C. J. and Jaffe, R. B. (1996). Vascular endothelial growth factor localization in human ovary and Fallopian tubes: possible role in reproductive function and ovarian cyst formation. J. Clin. Endocrinol. Metab., 81, 353-9
8. Yan, Z., Weich, H. A., Bernart, W., Breckwoldt, M. and Neulen, J. (1993). Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro. J. Clin. Endocrinol. Metab., 77, 1723-5
9. Tsafriri, A. and Adashi, E. Y. (1994). Local non-steroidal regulators of ovarian function. In Knobil, E. and Neill, J. D. (eds) The Physiology of Reproduction, 2nd ed., pp. 817-60. (New York: Raven Press)
10. Gospodarowicz, D., Cheng, J., Lui, G. M. and Bohlen, P. (1985). Corpus luteum angiogenic factor is related to fibroblast growth factor. Endocrinology, 117, 2283-391
11. Yamamoto, S., Konishi, I., Nanbu, K., Komatsu, T., Mandai, M., Kuroda, H., Matsushita, K. and Mori, T. (1997). Immunohistochemical localization of basic fibroblast growth factor (bFGF) during folliculogenesis in the human ovary. Gynecol. Endocrinol., 11, 223-30
12. Noyes, R. W., Hertig, A. T. and Rock, J. (1950). Dating the endometrial biopsy. Fertil. Steril., 1, 3-10
13. Gougeon, A. (1986). Dynamics of follicular growth in the human: a model from preliminary results. Hum. Reprod., 1, 81-7
14. Harrison-Woolrych, M. L., Sharkey, A. M., Charnock-Jones, D. S. and Smith, S. K. (1995). Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata. J. Clin. Endocrinol. Metab., 80, 1853-8
15. Celis, J. E., Bravo, R., Larsen, P. M. and Fey, S. J. (1984). Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells. Leuk. Res., 8, 143-57
16. Hall, P. A., Levinson, D. A., Woods, A. L., Yu, C. C. W., Kellock, D. B., Watkins, J. A., Barnes, D. M., Gillett, C. E., Camplejohn, R., Waseem, N. H. and Lane, D. P. (1990). Proliferating nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol., 162, 285-94
17. Parums, D. V., Cordell, J. L., Micklem, K., Heryet, A. R., Gatter, K. C. and Mason, D. Y. (1990). JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J. Clin. Pathol., 43, 752-7
18. Horak, E. R., Leek, R., Klenk, N., LeJeune, S., Smith, K., Stuart, N., Greenall, M., Stepniewska, K. and Harris, A. L. (1992). Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet, 340, 1120-4
19. Matsuzaki, K., Yoshitake, Y., Matuo, Y., Sasaki, H. and Nishikawa, K. (1989). Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc. Natl Acad. Sci. USA, 86, 9911-5
20. Nanbu, K., Konishi, I., Yamamoto, S., Koshiyama, M., Mandai, M., Komatsu, T., Li, W., Tokushige, M., Higuchi, K. and Mori, T. (1995). Minimal deviation adenocarcinorna of endometrioid type may arise in the isthmus. Gynecol. Oncol., 58, 136-41
21. Garrido, C., Saule, S. and Gospodarowicz, D. (1993). Transcriptional regulation of vascular endothelial growth factor gene expression in ovarian bovine granulosa cells. Growth Factors, 8, 109-17
22. Neulen, J., Yan, Z., Raczek, S., Weindel, K., Keck, C., Weich, H. A., Marmé, D. and Breckwoldt, M. (1995). Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J. Clin. Endocrinol. Metab., 80, 1967-71
23. Folkman, J., Klagsbrun, M., Sasse, J., Wadzinsky, M., Ingber, D. and Vlodavsky, I. (1988). A heparin-binding angiogenic protein-basic fibroblast growth factor is stored within basement membrane. Am. J. Pathol., 130, 393-400
24. Dissen, G. A., Lara, H. E., Fahrenbach, W. H., Costa, M. E. and Ojeda, S. R. (1994). Immature rat ovaries become revascularizcd rapidly after autotransplantation and show a gonadotropin-dependent increase in angiogenic factor gene expression. Endocrinology, 134, 1146-54
25. McClure, N., Healy, D. L., Rogers, P. A., Sullivan, J., Beaton, L., Haning, R. V., Connolly, D. T. and Robertson, D. M. (1994). Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet, 344, 235-6
26. Robertson, D., Selleck, K., Suikkari, A. M., Hurley, V., Moonhan, J. and Healy, D. (1995). Urinary vascular endothelial growth factor concentrations in women undergoing gonadotropin treatment. Hum. Reprod., 10, 2478-82
27. Krasnow, J. S., Zeleznik, A. J., Berga, S. L., Yeo, K. T. and Guzick, D. S. (1996). Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil. Steril., 65, 552-5